Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Bedford, Ohio-based Ben Venue Laboratories has issued a voluntary recall of one lot of its Acetylcysteine solution, 10 %, USP, due to a glass particle found floating in a vial in the affected lot.
Reports on medical device adverse events will soon be required to be submitted electronically, according to a final rule issued by the U.S. Food and Drug Administration, effective Aug. 14, 2015.
Boulder, Colo.-based JustRight Surgical has received 510(k) clearance from the U.S. Food and Drug Administration to market its 5mm Stapler, according to a news release.
Minnetonka, Minn.-based IMRIS received clearance from the U.S. Food and Drug Administration for the next generation of its VISIUS Surgical Theatre, an intraoperative imaging system.
The U.S. market for disposable medical supplies is projected to be valued at $49.3 billion by 2018, growing at a rate of 4.1 percent per year, according to a Report Linker report.
Florence, S.C.-based McLeod Health and St. Louis, Mo.-based ROi (Resource Optimization and Innovation) have signed a strategic supply chain agreement to improve clinical, financial and operational results for the health system, according to an ROi news release.
Most of the attention of the Patient Protection and Affordable Care Act is focused on the main actors who are center stage in the healthcare industry: citizens, physicians, government officials, payers. But the PPACA affects the industry on a deeper…
Cambridge, United Kingdom-based Team Consulting, a medical device design company, is incorporating the Japanese concepts of "poka-yoke" to its pharmaceutical packaging in attempts to reduce medical device usage errors, according to a company news release.
Computer hackers have broken into the system networks of three of the top medical device companies, according to a San Francisco Chronicle report.
In 2013, about $2.5 billion was invested in medical device development — which included 261 venture capital deals — the lowest rate since 2005, when $2.4 billion was invested over 251 deals, according to a Wall Street Journal report.